In particular, our findings need validation in non-Vietnamese populations, the mechanism by which LTA4H alters CSF cytokine expression and treatment response in patients with TBM needs elucidation, and whether HIV status and LTA4H genotype should be used to select patients for adjunctive corticosteroid needs to be addressed in randomized controlled trials. This evidence concerns the gene LTA4H and meningeal tuberculosis.